Hero Image

IJMS Webinar | Mitochondrial Function and Therapies

10 March 2026
15:00 (CET)
Online

Welcome from
the chair

Mitochondrial Function and Therapies

This webinar will focus on the crucial role played by mitochondria in maintaining cellular homeostasis and energy metabolism, as well as by mitochondrial redox signaling in the aging process. The role of mitochondria in cellular dysfunction will also be discussed, together with the limitations of treating neuronal mitochondrial dysfunction.

Date: 10 March 2026
Time: 2:00 pm UK time | 3:00 pm CET | 10:00 am EDT | 10:00 pm CST Asia
Webinar ID: 848 1149 5022
Webinar Secretariat: journal.webinar@mdpi.com



Meet the Event Chair

Dr. Iain P. Hargreaves
Dr. Iain P. Hargreaves
School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom

Meet Our Speakers

View all speakers
Dr. Iain P. Hargreaves

Dr. Iain P. Hargreaves

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom;
Dr. Iain P. Hargreaves is a Reader in Clinical Biochemistry at Liverpool John Moores University and an Hon. Associate Professor in Biochemistry at the University College of London. His research interests focus on mitochondrial dysfunction and oxidative stress in metabolic diseases. At present, he is investigating the causes and evidence of secondary mitochondrial dysfunction in lysosomal storage disease.

Dr. Gavin McStay

Dr. Gavin McStay

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom;
Dr. Gavin McStay is a senior lecturer in biotechnology at Liverpool John Moores University. He is interested in understanding quality control mechanisms and signal transduction pathways activated by mitochondrial stress and disease. His research examines the structure–function relationships of oxidative phosphorylation complexes, particularly Complex I and Complex IV, and how defects in mitochondrial architecture drive metabolic dysfunction and pathology. He combines biochemical, cellular, and molecular approaches to investigate mitochondrial signalling and energy metabolism. Gavin also directs Biomed News, a free platform for biomedical research literature discovery that currently has a particular focus on mitochondria.

Dr. Robert Heaton

Dr. Robert Heaton

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom;
Dr. Robert A. Heaton is a Lecturer in Biochemistry at Liverpool John Moores University whose research focuses on redox biology and mitochondrial signalling in human health and disease. His early work investigated reactive oxygen species as signalling molecules regulating skeletal muscle adaptation to exercise and the mechanisms underlying age-related muscle decline, with particular emphasis on mitochondrial ROS production and peroxiredoxin-mediated redox signalling. His current research expands these principles into translational models of human disease, including women’s reproductive health, where he studies how mitochondrial and lysosomal redox imbalance contributes to disorders such as adenomyosis and endometriosis. Across these areas, his work aims to define how redox signalling governs cellular adaptation, recovery, and maladaptation under physiological and pathological stress.

Dr. Adam Lightfoot

Dr. Adam Lightfoot

Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom;
Dr. Adam Lightfoot is Senior Lecturer in Cell & Molecular Physiology at Manchester Metropolitan University. Adam holds a PhD in Pathophysiology from the University of Liverpool (2011). He undertook postdoctoral training in the study of Idiopathic Inflammatory Myopathies and was appointed Lecturer at Manchester Met in 2016. Interspersed with an appointment in obesity medicine at Novo Nordisk in 2021, Adam currently leads a research group dedicated to the mechanistic study of muscle wasting and weakness. His research interests span the role of mitochondria and redox homeostasis in the pathogenesis of rare neuromuscular diseases (myositis), age-related loss of muscle mass and function, and obesity. With more recent focus on the development of functional human pre-clinical models of muscle/myopathies, as a platform for mechanistic interrogation.

Sponsors and Partners

Organizer


MDPIInternational Journal of Molecular Sciences (IJMS)
Recording

The full recording can be found below. In order to learn about future webinars, you can sign up to our newsletter by clicking “Subscribe” at the top of the page.

Relevant Special Issue

Mitochondrial Function and Therapies
Guest Editor: Dr. Iain P. Hargreaves
Deadline for manuscript submissions: 30 December 2026


Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility